Goldstein Michael H. 4
4 · OCULAR THERAPEUTIX, INC · Filed Mar 18, 2019
Insider Transaction Report
Form 4
Goldstein Michael H.
Chief Medical Officer
Transactions
- Purchase
Common Stock
2019-03-15$4.15/sh+10,000$41,500→ 13,686 total
Footnotes (1)
- [F1]Includes 2,986 shares acquired under the 2014 Ocular Therapeutix, Inc. Employee Stock Purchase Plan on December 31, 2018.